Taisho Acquires BMS Indonesia, OTC Assets; Price Tag Too High, Say Japanese Analysts

TOKYO - Japan's Taisho Pharmaceutical, the largest OTC drug maker in Japan, has reached an agreement to acquire most outstanding shares of PT Bristol-Myers Squibb Indonesia and trademarks and other brand assets held in Asia by BMS, for roughly ¥28 billion ($310 million), Taisho announced Sept. 15